<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mem Inst Oswaldo Cruz</journal-id><journal-id journal-id-type="iso-abbrev">Mem. Inst. Oswaldo Cruz</journal-id><journal-id journal-id-type="publisher-id">mioc</journal-id><journal-title-group><journal-title>Mem&#x000f3;rias do Instituto Oswaldo Cruz</journal-title></journal-title-group><issn pub-type="ppub">0074-0276</issn><issn pub-type="epub">1678-8060</issn><publisher><publisher-name>Instituto Oswaldo Cruz, Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27074253</article-id><article-id pub-id-type="pmc">4830113</article-id><article-id pub-id-type="doi">10.1590/0074-02760150436</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>The microbiological signature of human cutaneous leishmaniasis lesions
exhibits restricted bacterial diversity compared to healthy skin</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Salgado</surname><given-names>Vanessa R</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Queiroz</surname><given-names>Artur TL</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sanabani</surname><given-names>Sabri S</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Camila I</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Carvalho</surname><given-names>Edgar M</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Jackson ML</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barral-Netto</surname><given-names>Manoel</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barral</surname><given-names>Aldina</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="c01">
<sup>+</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Centro de Pesquisas Gon&#x000e7;alo Moniz, Salvador, BA,
Brasil</aff><aff id="aff2"><label>2</label>Instituto de Investiga&#x000e7;&#x000e3;o em Imunologia, S&#x000e3;o Paulo, SP, Brasil</aff><aff id="aff3"><label>3</label>Faculdade de Medicina da Universidade de S&#x000e3;o Paulo, Hospital das
Cl&#x000ed;nicas, Departamento de Patologia, S&#x000e3;o Paulo, SP, Brasil</aff><aff id="aff4"><label>4</label>Universidade Federal da Bahia, Hospital Universit&#x000e1;rio Prof Edgard
Santos, Servi&#x000e7;o de Imunologia, Salvador, BA, Brasil</aff><aff id="aff5"><label>5</label>Instituto Nacional de Ci&#x000ea;ncia e Tecnologia em Doen&#x000e7;as Tropicais,
Salvador, BA, Brasil</aff><author-notes><corresp id="c01"><label>+</label> Corresponding author: <email>abarral@bahia.fiocruz.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>4</month><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>111</volume><issue>4</issue><fpage>241</fpage><lpage>251</lpage><history><date date-type="received"><day>25</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>1</day><month>3</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><p>Localised cutaneous leishmaniasis (LCL) is the most common form of cutaneous
leishmaniasis characterised by single or multiple painless chronic ulcers, which
commonly presents with secondary bacterial infection. Previous culture-based studies
have found staphylococci, streptococci, and opportunistic pathogenic bacteria in LCL
lesions, but there have been no comparisons to normal skin. In addition, this
approach has strong bias for determining bacterial composition. The present study
tested the hypothesis that bacterial communities in LCL lesions differ from those
found on healthy skin (HS). Using a high throughput amplicon sequencing approach,
which allows for better populational evaluation due to greater depth coverage and the
Quantitative Insights Into Microbial Ecology pipeline, we compared the
microbiological signature of LCL lesions with that of contralateral HS from the same
individuals.<italic>Streptococcus</italic>,
<italic>Staphylococcus</italic>,<italic>Fusobacterium</italic> and other strict or
facultative anaerobic bacteria composed the LCL microbiome. Aerobic and facultative
anaerobic bacteria found in HS, including environmental bacteria, were significantly
decreased in LCL lesions (p &#x0003c; 0.01). This paper presents the first comprehensive
microbiome identification from LCL lesions with next generation sequence methodology
and shows a marked reduction of bacterial diversity in the lesions.</p></abstract><kwd-group><kwd>microbiome</kwd><kwd>LCL</kwd><kwd>wound</kwd><kwd>healthy skin</kwd><kwd>high-throughput sequencing</kwd></kwd-group><counts><fig-count count="6"/><table-count count="1"/><equation-count count="0"/><ref-count count="47"/><page-count count="11"/></counts></article-meta></front><body><p>Cutaneous leishmaniasis (CL) is broadly divided into three major clinical phenotypes:
diffuse CL (DCL), presenting multiple nonulcerative nodules, mucosal leishmaniasis (LM),
characterised by destructive mucosal inflammation, and localised CL (LCL), the most
frequent manifestation of CL, characterised by single or multiple painless chronic
ulcerative skin lesions, developing at the site of the infected sandfly bite (<xref rid="B34" ref-type="bibr">Reithinger et al. 2007</xref>, <xref rid="B8" ref-type="bibr">Costa et al. 2009</xref>). CL in the New World is caused mainly by<italic>Leishmania
(Viannia) braziliensis</italic>, <italic>Leishmania (Viannia) guyanensis</italic>,
<italic>Leishmania (Leishmania) amazonensis</italic>, and<italic>Leishmania (Leishmania)
mexicana</italic> (Grimaldi Jr et al. 1989). In the Northeast Region of Brazil, LCL and
LM are predominantly caused by <italic>L. (V.) braziliensis</italic> (<xref rid="B36" ref-type="bibr">Rosa et al. 1988</xref>) and DCL is most commonly caused by <italic>L.
amazonensis</italic> (<xref rid="B4" ref-type="bibr">Bittencourt et al.
1989</xref>)<italic>.</italic>
</p><p>LCL ulcers usually present with a slow recovery and may last several months or years in the
absence of antiparasitic treatment (<xref rid="B38" ref-type="bibr">Salman 1999</xref>).
Therapy is broadly accomplished with pentavalent antimonials (Glucantime<sup>&#x000ae;</sup>;
Sanofi-Aventis, Brazil) recommended as first line drugs. Therapeutic response to these
drugs is usually favourable, presenting variable cure rates (from 60-100%) (<xref rid="B2" ref-type="bibr">Azeredo-Coutinho et al. 2007</xref>). The ulcer chronicity,
constant environmental exposure, and poor hygiene at the lesion site associated with ground
proximity in lesions located in lower limbs, one of the most affected site, may promote
polymicrobial infections. Secondary bacterial infections are frequently observed in LCL
patients. This condition, in addition to being uncomfortable for the patient, may sometimes
impair the healing process of ulcer and require antibiotic treatment (<xref rid="B43" ref-type="bibr">Vera et al. 2002</xref>,<xref rid="B42" ref-type="bibr">2006</xref>, <xref rid="B13" ref-type="bibr">Fontes et al. 2005</xref>, <xref rid="B15" ref-type="bibr">Gon&#x000e7;alves et al. 2009</xref>).</p><p>Prejudicial effects on the healing process have been reported in the presence of a complex
bacterial colonisation also in diabetic lesions and of other chronic wounds (<xref rid="B9" ref-type="bibr">Daltrey et al. 1981</xref>, <xref rid="B21" ref-type="bibr">Halbert et al. 1992</xref>, <xref rid="B11" ref-type="bibr">Davies et al. 2004</xref>,
<xref rid="B19" ref-type="bibr">Grice et al. 2010</xref>, <xref rid="B33" ref-type="bibr">Percival et al. 2010</xref>, <xref rid="B39" ref-type="bibr">Scales &#x00026;
Huffnagle 2013</xref>). In LCL lesions, it was observed that individuals presenting
secondary infection with purulent secretion and harbouring concomitant infections with
<italic>Streptococcus pyogenes</italic>,<italic>Staphylococcus aureus</italic>,
<italic>Pseudomonas aeruginosa</italic>,<italic>Morganella morganii</italic>, and
<italic>Enterococcus durans</italic>presented with a delayed healing process (<xref rid="B23" ref-type="bibr">Isaac-M&#x000e1;rquez &#x00026; Lezama-D&#x000e1;vila 2003)</xref>. In other
study, patients presenting secondary bacterial infection in CL lesions presented lower cure
rates to systemic treatment with glucantime compared with patients who did not presenting
contamination. Authors suggest decreased effect of glucantime in CL lesions complicated
with secondary bacterial infection. <italic>S. aureus</italic> was the most prevalent
organism in these contaminated lesions (<xref rid="B37" ref-type="bibr">Sadeghian et al.
2011)</xref>. The delayed time in CL lesion healing requires repeated treatment cycles,
with harmful effects associated with drug toxicity (<xref rid="B30" ref-type="bibr">Mitropoulos et al. 2010)</xref>.</p><p>
<xref rid="B31" ref-type="bibr">Naik et al. (2012)</xref> evaluated the role of skin
microbiota on local immunity using germ-free (GF) and specific pathogen free (SPF) mice in
a model of dermal infection induced by <italic>L. major</italic>. GF mice infected
intradermally with <italic>L. major</italic> showed smaller lesions with reduced oedema and
necrosis compared to SPF mice, however with higher parasite load in the lesion. These
outcomes were associated with a smaller production of interferon-gamma and tumour necrosis
factor-alpha by cutaneous T-cell and demonstrated the role of skin microbiota in
<italic>Leishmania</italic> infection control. Previous studies comparing GF and
conventional (microbiota-bearing) mice infected subcutaneously with <italic>L.
major</italic> (revised by <xref rid="B27" ref-type="bibr">Lopes et al. 2016</xref>)
demonstrated GF mice failed to heal lesions and presented higher parasite load at the
infection site than conventional mice. The cytokine production profile did not differ in
both; however macrophages from GF mice were not as efficient at killing parasites as
conventional mice, suggesting an important role of microbiota in macrophage activation
(<xref rid="B32" ref-type="bibr">Oliveira et al. 2005</xref>). <xref rid="B44" ref-type="bibr">Vieira et al. (1998)</xref> also found similar results with GF mice failing to
resolve lesions after 13 weeks of <italic>L. major</italic> infection, in contrast with the
conventional mice. Despite this, the cytokine profiles were indistinguishable in both
groups. GF mice macrophages, albeit capable of producing nitric oxide (NO) in response to
leishmanial infection, were no able to destroy the parasites. Absence of the normal
indigenous microbiota was suggested as cause of increased susceptibility to <italic>L.
major</italic> infection (<xref rid="B44" ref-type="bibr">Vieira et al.
1998</xref>).</p><p>However, the leishmaniasis microbiome-composition in humans remains unclear. Few studies
for bacterial community identification in LCL lesions have been performed. Previous
culture-based studies reported <italic>Staphylococcus</italic>
spp,<italic>Streptococcus</italic> spp, <italic>Enterococcus</italic>
spp,<italic>Pseudomonas</italic> spp, and other opportunistic bacteria in LCL lesions
(<xref rid="B42" ref-type="bibr">Vera et al. 2006</xref>, <xref rid="B40" ref-type="bibr">Shirazi et al. 2007</xref>, <xref rid="B47" ref-type="bibr">Ziaei et al.
2008</xref>, <xref rid="B15" ref-type="bibr">Gon&#x000e7;alves et al. 2009</xref>).
Nevertheless, this culture-based methodology has a strong bias for estimation of bacterial
composition since bacteria presenting low relative abundance, fastidious and/or
&#x0201c;unculturable&#x0201d; organisms are underestimated (<xref rid="B35" ref-type="bibr">Rhoads et al.
2012</xref>, <xref rid="B39" ref-type="bibr">Scales &#x00026; Huffnagle 2013</xref>).</p><p>Advanced molecular methods have indicated that only about 1% or 2% of all the
skin-colonising bacteria could be cultivated under usual conditions (<xref rid="B16" ref-type="bibr">Gontcharova et al. 2010</xref>, <xref rid="B3" ref-type="bibr">Bertesteanu et
al. 2014</xref>). Furthermore, culture-independent tests revealed a much greater
diversity in skin bacterial communities compared to culture-based estimations (<xref rid="B18" ref-type="bibr">Grice &#x00026; Segre 2011</xref>, <xref rid="B35" ref-type="bibr">Rhoads et al. 2012</xref>, <xref rid="B39" ref-type="bibr">Scales &#x00026; Huffnagle
2013)</xref>. The use of massive molecular methods allows deep insights into the
microbiome-composition in general and also in the LCL microbiome because it is more
sensitive than culture, as described for other chronic wounds (<xref rid="B35" ref-type="bibr">Rhoads et al. 2012)</xref>. Our hypothesis is that bacterial communities in
LCL lesions differ from those on contralateral healthy skin (HS). Thus, our aim was to
characterise the LCL lesion microbiome and to compare it to that found on HS, in the same
individuals, using next generation sequencing.</p><sec><title>SUBJECTS, MATERIALS AND METHODS</title><p>
<italic>Patient characterisation</italic> - The median age from subjects was 35 years
(range 20-48 years). Subjects were two women and eight men without significant
differences related to gender. Individuals chosen for the study lived in the endemic
area an average of 32.3 years (range 8-44 years), most had agricultural activity, and
presented ulcerated skin lesions clinically consistent with CL (<xref rid="B8" ref-type="bibr">Costa et al. 2009</xref>). Patients were confirmed with CL after positive
results in, at least, one of the following tests realised to the inclusion of them in
the study: delayed-type hypersensitivity (DTH) with<italic>Leishmania</italic> antigen,
parasite isolation in culture, parasite identification in histopathological studies, or
a positive <italic>L. braziliensis</italic> polymerase chain reaction (PCR) performed,
as previously described (<xref rid="B45" ref-type="bibr">Weirather et al. 2011</xref>).
No patient had received previous treatment for leishmaniasis or antibiotics in the last
month before sample collection.</p><p>
<italic>Wound samples and HS collection</italic> - Samples were collected in The Health
Post of Corte de Pedra, state of Bahia, Brazil, a CL endemic area. Twenty paired swab
samples (10 samples collected from LCL lesions and 10 samples collected from
contralateral HS) were obtained using sterile technique after wound cleaning with saline
and debridement, when a crust was present. The material collected in swab samples was
transferred to MO BIO PowerBead Tubes (PowerSoil DNA Isolation kit; MO BIO Laboratories,
Inc, USA) and immediately frozen at -80&#x000ba;C until DNA isolation.</p><p>
<italic>Management of patients</italic> - After sample collection, patients were treated
with intravenous pentavalent antimony Sb<sup>V</sup> (20 mg/kg/day for 20 days). The
lesion outcome was observed up to the healing. Patients who had failure of treatment
after the first course and the lesion persisted after 90 days after initiation of
treatment received a second course of Sb<sup>V</sup> (20 mg/kg/day for 20 days). A third
Sb<sup>V</sup> course in combination with pentoxifylline (400 mg/kg/3 times daily)
was administrated to patients who had persistence of the lesion 60 days after initiation
of the second Sb<sup>V</sup> course (<xref rid="B28" ref-type="bibr">Machado et al.
2002</xref>).</p><p>
<italic>LCL lesion and HS sample DNA isolation</italic> - Bacterial DNA isolation was
performed according to the PowerSoil DNA Isolation Kit (MO BIO) manufacturer&#x02019;s
instructions. DNA amounts were measured using the Qubit Quant-iT dsDNA BR Assay Kit
protocol (Life Technologies, USA). Laminar flows and reagents used in DNA isolation were
treated with ultraviolet before use to reduce the risk of contamination. DNA was
submitted to V4 16S rRNA PCR amplification as described below.</p><p>
<italic>16S rRNA barcode library preparation and sequencing</italic> - For each patient,
two different amplicon libraries were prepared: one from LCL ulcers and the other from
HS. The hypervariable V4 region of the 16S rRNA gene from each sample was amplified in
triplicate using a primer set (515f/806r), as previously described (<xref rid="B6" ref-type="bibr">Caporaso et al. 2011</xref>, <xref rid="B5" ref-type="bibr">2012</xref>). Amplification reactions were performed using the FastStart High
Fidelity PCR System (Roche Applied Science, Germany) with a final volume of 25 &#x003bc;L
containing 1.8 mM MgCl<sub>2</sub>, 200 &#x003bc;M dNTP, 0.4 &#x003bc;M primer (515f and 806r), 2.5 U
FastStart High Fidelity Enzyme Blend, and a 100 ng/&#x003bc;L DNA sample. The PCR conditions
were as follows: an initial step of 3 min at 94&#x000ba;C, 35 cycles consisting of 45 s at 94&#x000ba;C,
60 s at 50&#x000ba;C, and 90 s at 72&#x000ba;C, and a final step of 10 min at 72&#x000ba;C. Amplicons were
visualised using 1.5% agarose gels and ethidium bromide nucleic acid gel stain in a 0.5x
tris-borate-ethylenediamine tetraacetic acid buffer. To confirm that the PCR reagents
were not source of bacterial sequences, no-template control PCR was performed. No
visible amplification signal was observed in this negative control on a gel, indicating
that bacterial contamination was minimal.</p><p>The triplicate PCR products were pooled and purified using the PureLink PCR Purification
Kit (Life Technologies), according to the manufacturer&#x02019;s instructions. Following
purification, each library was normalised to ensure equal library representation in
pooled samples. The final libraries were pooled at equimolar concentration, denatured,
and mixed with PhiX control to increase sequence diversity. Finally, the prepared
library was loaded onto an Illumina MiSeq clamshell style cartridge for sequencing.</p><p>
<italic>Processing and analysis of 16S rRNA sequences</italic> - After sequencing, all
16 rRNA raw sequence data were demultiplexed, quality-filtered, and analysed using
Quantitative Insights Into Microbial Ecology (QIIME) v.1.7.0 pipeline (<xref rid="B26" ref-type="bibr">Kuczynski et al. 2012</xref>). After assignment of
sequences, primer and tag sequences were removed before operational taxonomic unit (OTU)
clustering. OTU clustering was performed with a 97% similarity threshold. Taxonomic
identities were assigned using the RDP classifier tool (v.10.28) with 0.97 confidence
threshold using Greengenes Database (from May 2013). Different numbers of reads per
sample were obtained. Therefore, the sequence data were rarefied at 400,000 sequences
per sample to account for this variation for Chao and observed species index
calculations (i.e., alpha diversity), and principal coordinates analysis (PCoA) was
performed using the phylogeny-based unweighted UniFrac distance metric (i.e., beta
diversity).</p><p>
<italic>Statistical analyses</italic> - Identification of OTUs that were significantly
different in abundance in LCL lesions and contralateral HS was performed by paired
<italic>t</italic> test with Bonferroni correction. To determine whether any groups
of samples contained significantly different bacterial communities, analysis of
similarities (ANOSIM) was conducted. Using the unweighted UniFrac distance matrix,
distances were grouped as &#x0201c;within group&#x0201d; or &#x0201c;between group&#x0201d;. Significance levels were
calculated by comparing the R statistic against the distribution generated from 10,000
permutations of the randomised dataset. The data were entered into a custom database
(Excel, Microsoft Corp) and analysed using Prism 5. Quantitative data were reported as
mean &#x000b1; standard deviation or median (1st and 3rd quartile). Categorical data were
reported as percentage and 95% confidence interval. Within patient phylum and genus
level differences between lesions and HS were compared using multiple Wilcoxon rank
tests for paired data. A p-value less than 0.05 were considered to be statistically
significant.</p><p>
<italic>Availability of supporting data</italic> - Raw sequences were deposited in the
National Center for Biotechnology Information Short Read Archive (ncbi.nlm.nih.gov/sra)
and are available with the following accessions: SAMN03198271, SAMN03198273,
SAMN03198274, SAMN03198275, SAMN03198276, SAMN03198277, SAMN03198314, SAMN03198315,
SAMN03198316, and SAMN03198317.</p><p>
<italic>Ethics</italic> - The Gon&#x000e7;alo Moniz Research Centre/Oswaldo Cruz Foundation
Ethical Committee approved the study (IRB 000026120; CEP 339/2010). The Declaration of
Helsinki protocols were followed and all subjects provided written consent prior to
participation in the study.</p></sec><sec sec-type="results"><title>RESULTS</title><p>
<italic>Cohort description</italic> - To evaluate bacterial communities in LCL lesions,
10 subjects presenting ulcerated skin lesions with circular contours, infiltrative
borders painless, and background with crude granules, epidemiologically and clinically
consistent with LCL (<xref rid="B8" ref-type="bibr">Costa et al. 2009</xref>), were
included in the study. One patient showed multiple lesions located mainly in the lower
limbs, while the other nine patients presented single ulcers at different body sites
shown in <xref ref-type="table" rid="t1">Table</xref>. These sites are the most frequent
associated to LCL lesions in our experience (data not shown). <xref ref-type="table" rid="t1">Table</xref> also reported the demographic data, clinical characteristics,
results of<italic>Leishmania</italic> diagnosis tests, and LCL lesion outcome for the
patients included in the study.</p><p>
<table-wrap id="t1" orientation="portrait" position="float"><label>TABLE</label><caption><title>Demographic and clinical data, results of
<italic>Leishmania</italic>diagnosis tests and LCL lesion outcome from patients
in the study</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" style="font-weight:normal" rowspan="1" colspan="1">Patients</th><th style="font-weight:normal" rowspan="1" colspan="1">Age/ sex</th><th style="font-weight:normal" rowspan="1" colspan="1">Occupation</th><th style="font-weight:normal" rowspan="1" colspan="1">Years living in
endemic area</th><th style="font-weight:normal" rowspan="1" colspan="1">Wounds (n)</th><th style="font-weight:normal" rowspan="1" colspan="1">Wound location</th><th style="font-weight:normal" rowspan="1" colspan="1">Wound size (mm)</th><th style="font-weight:normal" rowspan="1" colspan="1">DTH with
<italic>Leishmania</italic>antigen</th><th style="font-weight:normal" rowspan="1" colspan="1">
<italic>Leishmania brasiliensis</italic> PCR</th><th style="font-weight:normal" rowspan="1" colspan="1">Parasite isolation in
culture</th><th style="font-weight:normal" rowspan="1" colspan="1">Parasite
identification in histopathology</th><th style="font-weight:normal" rowspan="1" colspan="1">Sb<sup>V</sup> course
numbers to healing</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">44/ F</td><td align="center" rowspan="1" colspan="1">Domestic worker</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Hand</td><td align="center" rowspan="1" colspan="1">10 x 15</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">48/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Middle of leg</td><td align="center" rowspan="1" colspan="1">20 x 17</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">39/ F</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Thigh</td><td align="center" rowspan="1" colspan="1">25 x 25</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">28/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Shin</td><td align="center" rowspan="1" colspan="1">15 x 12</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">28/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Shin</td><td align="center" rowspan="1" colspan="1">9 x 7</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">20/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Middle of leg</td><td align="center" rowspan="1" colspan="1">15 x 13</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">23/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Shin</td><td align="center" rowspan="1" colspan="1">20 x 20</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">43/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Thigh</td><td align="center" rowspan="1" colspan="1">15 x 12</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">31/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Shin</td><td align="center" rowspan="1" colspan="1">15 x 15</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">39/ M</td><td align="center" rowspan="1" colspan="1">Agricultural worker</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">Middle of leg</td><td align="center" rowspan="1" colspan="1">10 x 7</td><td align="center" rowspan="1" colspan="1">POS</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">NEG</td><td align="center" rowspan="1" colspan="1">3</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>DTH: delayed type hypersensitivity; F: female; M: male; NEG: negative; PCR:
polymerase chain reaction; POS: positive.</p></fn></table-wrap-foot></table-wrap>
</p><p>All subjects presented positive results in the DTH test with<italic>Leishmania</italic>
antigen (<xref ref-type="table" rid="t1">Table</xref>). Parasites were isolated in
culture from patients 3 and 5. Parasites were also detected in histopathological exams
of patients 6 and 7. All patients, except 3, 7, and 10, tested positive in the
<italic>L. braziliensis</italic> PCR (<xref rid="B45" ref-type="bibr">Weirather et
al. 2011</xref>). Patient 10 was the only one that the direct tests (culture,
histopathology, or PCR) were negative. However, this patient presented an
epidemiological history compatible with leishmaniasis (living for 39 years in the
endemic area in an agricultural working), positive results in DTH test, and multiple
lesions in lower limbs clinically very characteristic of LCL.</p><p>In relation to the lesions outcome after treatment, seven patients had complete
regression of the lesion after the first Sb<sup>V</sup> course (<xref ref-type="table" rid="t1">Table</xref>). Three patients (5, 9, and 10) showed treatment failure after
the first Sb<sup>V</sup> course and received a second course of Sb<sup>V</sup>. Only for
patient 10 was necessary a third Sb<sup>V</sup> course in combination with
pentoxifylline. All patients showed complete lesion regression after treatment,
consistent with leishmaniasis infection.</p><p>
<italic>Analysis of 16S rRNA sequences -</italic> To evaluate whether bacterial
communities in LCL lesions differed from those found on HS, samples from 10 different
laboratorial and clinical confirmed LCL lesions and from the corresponding contralateral
HS of the same patient were sequenced using a high throughput amplicon sequencing
methodology. Demultiplexed 16 rRNA raw sequence data were quality-filtered and analysed
using QIIME. After the quality filter checks, 13,759,042 high quality reads were
obtained: 7,823,305 reads were from HS and 5,935,737 reads from LCL lesions. The mean
sequence number per sample was 687,952.1 &#x000b1; 101,984 (range from 408,767-927,648). The
average length of sequences was 251 bp. Thirty-one phyla and 862 OTUs were identified in
Greengenes Database. The lesion sample reads from patient 9 were excluded from
statistical analysis because almost 90% of sequences from this patient were not
classified into any phyla or OTU.</p><p>
<italic>Alpha and beta diversity -</italic> Rarefaction measurements (alpha diversity),
shown in <xref ref-type="fig" rid="f01">Fig. 1</xref>, demonstrated significant
differences in observed species and Chao indices between the HS microbiome vs. LCL
lesions denoting that HS presented significantly higher diversity levels compared to LCL
wounds (p &#x0003c; 0.01).</p><p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>: rarefaction analysis for the Chao index (A) and observed species (B) of
16S rRNA sequences obtained from localised cutaneous leishmaniasis (LCL)
lesions (square) and contralateral healthy skin (HS) (sphere). Lines represent
the average of each group while the error bars represent the standard
deviations.</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf01"/></fig>
</p><p>PCoA plots based on unweighted UniFrac distance matrix (beta diversity), shown in<xref ref-type="fig" rid="f02">Fig. 2</xref>, exhibits separation between most HS and LCL
lesion samples (ANOSIM, R = 0.58, p = 0.002) indicating that the LCL lesion microbiome
differs from HS. PCoA also suggests that HS (red) has more samples with similar
bacterial composition to each other than the LCL lesion. In addition, PCoA showed a mild
cluster of samples of HS (red) related to the body sites where these samples were
collected. Shin, thigh, and leg were grouped near to other samples from the same
site.</p><p>
<fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>: principal coordinates analysis (PCoA) of unweighted UniFrac distances
between localised cutaneous leishmaniasis (LCL) lesions (blue) and
contralateral healthy skin (HS) (red) samples. The percentage of variation
explained by each PCoA is indicated on the axis.</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf02"/></fig>
</p><p>
<italic>Differences in LCL lesions and HS microbial community at phylum level</italic> -
Thirty-one bacterial phyla were detected in both LCL lesions and HS. Most sequences
detected in LCL lesions and HS were assigned to five phyla: Firmicutes, Actinobacteria,
Proteobacteria, Fusobacteria, and Bacteroidetes. Chloroplast/Cyanobacteria were also
detected in all HS samples and in LCL lesions from two patients. <xref ref-type="fig" rid="f03">Fig. 3</xref> shows the relative abundance of these phyla was variable
considering the sampled skin sites from HS and LCL lesions. Unknown phyla in <xref ref-type="fig" rid="f03">Fig. 3</xref> represent sequences that have not been
classified with the database used. This limitation occurs due the query insufficient
alignment scores with the sequences database or low probability with RDP classifier.</p><p>
<fig id="f03" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>: topographical distribution of bacterial phyla detected in localised
cutaneous leishmaniasis (LCL) lesions and healthy skin (HS) samples by
high-throughput Illumina sequencing. Pie charts represent the major bacterial
phyla found in different topographic body sites (hand, thigh, middle of leg,
and shin).</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf03"/></fig>
</p><p>
<xref ref-type="fig" rid="f04">Fig. 4</xref> shows the cumulative percentages of
sequences from bacterial phyla detected in HS and LCL lesions. The vast majority of
sequences detected in LCL lesions were members of Firmicutes (54.3%), Actinobacteria
(11.7%), Fusobacteria (11.6%), Proteobacteria (8.7%), and Bacteroidetes (5.1%).
Firmicutes were more frequent in LCL lesions (54.3%) than HS (34.6%). This phylum&#x02019;s
abundance was significantly higher (p = 0.02) in LCL lesions. Actinobacteria and
Proteobacteria were detected in LCL lesions, however with significantly lower
percentages compared to HS (HS 26.2% vs. 11.7% LCL and HS 21.8% vs. 8.7% LCL,
respectively). Cyanobacteria showed very low percentages in LCL lesions (0.1%) compared
to HS (2%). The presence of this phylum in HS also differed significantly from LCL
lesions (p = 0.001). One of the major phyla detected in LCL lesions was Fusobacteria,
however without statistical significance. Bacteroidetes showed low percentages in both
sites (LCL 5.1% vs. 4.9% HS).</p><p>
<fig id="f04" orientation="portrait" position="float"><label>Fig. 4</label><caption><title>: cumulative percentages of sequences from bacterial phyla detected by
high-throughput Illumina sequencing in healthy skin (HS) (white bars) and
localised cutaneous leishmaniasis (LCL) lesion samples (dark bars) compared
using multiple Wilcoxon rank tests for paired data.</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf04"/></fig>
</p><p>
<italic>Differences in LCL lesions and HS microbiota at genus level</italic> - About 862
bacterial genera were found in LCL lesions and HS, however the 33 genera demonstrated in
<xref ref-type="fig" rid="f05">Fig. 5</xref> were the most common at both sites with
relative abundances ranging the sampled skin sites (hand, middle leg, shin, and thigh)
from HS and LCL. These were the bacterial genera which presented relative abundance
greater than or equal to 2.5%.</p><p>
<fig id="f05" orientation="portrait" position="float"><label>Fig. 5</label><caption><title>: relative abundance of most bacterial genera detected in 20 swab samples
from healthy skin (HS) and localised cutaneous leishmaniasis (LCL) lesions by
high-throughput Illumina sequencing. Bars represent the relative abundances
between the majorities of genera detected in each sample.</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf05"/></fig>
</p><p>
<xref ref-type="fig" rid="f06">Fig. 6</xref> shows the cumulative percent of bacterial
sequences in HS and LCL lesions and also the significant differences found in LCL
lesions and HS microbiome. Bacterial genera were separated by the O2 tolerance to
facilitate the preview. <italic>Streptococcus</italic> was the only genus found
significantly increased in LCL lesions compared to HS (p = 0.01). Although not
statistically significant, LCL lesions showed increased levels of strict and/or
facultative anaerobic bacteria compared to HS. Moreover, about 15 environmental
bacterial genera were significantly decreased in LCL lesions compared to HS, as shown in
<xref ref-type="fig" rid="f06">Fig. 6</xref>.</p><p>
<fig id="f06" orientation="portrait" position="float"><label>Fig. 6</label><caption><title>: bacterial genera detected by high-throughput Illumina sequencing in
healthy skin (HS) (white bars) and localised cutaneous leishmaniasis (LCL)
lesions (dark bars) samples compared using multiple Wilcoxon rank tests for
paired data. A: cumulative percent of aerobic bacterial sequences in HS and LCL
lesions; B: cumulative percent of anaerobic facultative and microaerophilic
bacterial sequences in HS and LCL lesions; C: cumulative percent of strict
anaerobic bacterial sequences in HS and LCL lesions; D: mean cumulative percent
of sequences from anaerobic, facultative anaerobic/microaerophilic, and aerobic
bacteria in HS and LCL.</title></caption><graphic xlink:href="0074-0276-mioc-111-004-0241-gf06"/></fig>
</p><p>Considering the LCL lesions microbiome, the ubiquitous genera
were<italic>Staphylococcus</italic> (present in all patients), followed
by<italic>Streptococcus</italic> (detected in 8 of 9
patients),<italic>Corynebacterium</italic>, and <italic>Peptoniphilus</italic> (found
in 7 of 9 patients), <italic>Peptostreptococcus</italic>,
and<italic>Fusobacterium</italic> (observed in 6 and 5 patients,
respectively).<italic>Staphylococcus</italic>, <italic>Streptococcus</italic>,
and<italic>Fusobacterium</italic> were the predominant genera in lesion samples of
patient 5 and 10, as observed in <xref ref-type="fig" rid="f05">Fig. 5</xref>. These
patients presented with a delayed healing process and took two and three cycles of
leishmanicidal drugs, respectively, to complete the healing of the lesion.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>We compare the microbiological composition of laboratorial and LCL lesions with the
contralateral HS microbiome from the same individuals using high throughput amplicon
sequencing approach, which allows for deeper and broader insight into microbiological
diversity. Our results showed that cutaneous microbiological signatures in human
leishmaniasis lesions from patients living in an area with high predominance of
<italic>L. braziliensis</italic> transmission (up to 95%) (<xref rid="B36" ref-type="bibr">Rosa et al. 1988</xref>) exhibit restricted bacterial diversity compared to
those of HS. Three out of 10 patients did not show positive results in PCR. In these
cases, it was not possible to identify the implicated<italic>Leishmania</italic>. Two of
these patients did not show delayed healing, but presented parasites in
histopathological examination (patient 3) and culture (patient 7). The negative results
of patients 3 and 7 in the PCR could be explained by the presence of inhibitors in the
isolated DNA of these patients, which hamper the amplification of target DNA in the PCR
reaction. Different samples could also be used in the PCR and other tests (histology and
culture) which caused this conflict in the results. Only patient 10 showed delayed
healing and had negative results in the direct tests, suggesting that the PCR and other
tests had insufficient sensitivity for this patient diagnosis. Although we did not
identify other<italic>Leishmania</italic> species in these patients, it is likely they
were infected with <italic>L. braziliensis</italic> or <italic>L. amazonensis</italic>.
As only, these two species were identified in human cases from this endemic area.
However, <italic>L. amazonensis</italic> is mainly associated with other clinical
manifestation as DCL (<xref rid="B8" ref-type="bibr">Costa et al. 2009</xref>).</p><p>Both rarefaction measures and PCoA (alpha and beta diversity) results suggest that LCL
and HS microbiome composition is different (Figs 1, 2). This result shows that
compositionally intact HS bacterial colonisation is different from the opened wound with
compromised epidermis caused by <italic>Leishmania</italic> infection. This microbiome
composition variation in LCL lesions is probably because an open wound with compromised
epidermis, associated with a subjacent inflammation caused
by<italic>Leishmania</italic>, provides unbalance in indigenous microbial components
(<xref rid="B39" ref-type="bibr">Scales &#x00026; Huffnagle 2013</xref>). Our results
suggest that the disturbance in LCL lesions is associated with an opportunistic
contamination by commensal bacteria, which could resist to subjacent inflammation
promoted by <italic>Leishmania</italic>, and develop against less adapted bacteria. In
addition, this condition could provide pathogenic colonisation from different
aetiologies (<xref rid="B39" ref-type="bibr">Scales &#x00026; Huffnagle 2013)</xref>.</p><p>Moreover, PCoA shows HS has more samples with similar composition to each other than the
LCL lesion, probably because patients have similar microbiota related to the
topographical body sites (Figs 2, 3). This site-dependent grouping based on the
bacterial composition in the skin has already been described (<xref rid="B17" ref-type="bibr">Grice et al. 2009</xref>, <xref rid="B25" ref-type="bibr">Kong &#x00026; Segre
2012</xref>).</p><p>The LCL microbiome showed lower diversity compared to HS. This restricted bacterial
diversity in microbial community in affected compared to HS has also been reported in
both inflammatory or not skin diseases, such as diabetic ulcers (<xref rid="B16" ref-type="bibr">Gontcharova et al. 2010</xref>), psoriasis (<xref rid="B1" ref-type="bibr">Alekseyenko et al. 2013</xref>), and atopic dermatitis (<xref rid="B24" ref-type="bibr">Kong et al. 2012</xref>). High bacterial diversity is associated with host
protection, by innate and adaptive immune system modulation (<xref rid="B19" ref-type="bibr">Grice et al. 2010</xref>, <xref rid="B18" ref-type="bibr">Grice &#x00026; Segre
2011</xref>, <xref rid="B25" ref-type="bibr">Kong &#x00026; Segre 2012)</xref>. The
inflammation triggered by the innate immune system provides a suitable environment to
some commensal bacteria, which could resist to the subjacent inflammation promoted
by<italic>Leishmania</italic> and hampering development of less adapted bacteria.</p><p>Another explanation for the bacterial diversity reduction in LCL is the competition and
cooperation behaviour in mixed microbial population, as bacteriocin and virulence factor
production, which are commonly described in interspecies bacterial competition (<xref rid="B39" ref-type="bibr">Scales &#x00026; Huffnagle 2013</xref>). Most adapted bacteria
could influence development of another bacterium in a LCL environment.</p><p>We observed in HS samples a similar composition to the skin microbiome composed by the
following phyla: Actinobacteria, Firmicutes, Bacteroidetes, and Proteobacteria (<xref rid="B18" ref-type="bibr">Grice &#x00026; Segre 2011</xref>). Despite being less
frequent, Cyanobacteria and Fusobacteria were also observed, suggesting microbiome
composition variation for patients from our endemic area. Concerning the LCL microbiome,
a similar microbial community was found in the microbiome of nonhealing diabetic foot
ulcers, with similar percentages of Firmicutes (67%), Actinobacteria (14%),
Proteobacteria (9.8%), Bacteroidetes (7.3%), and Fusobacteria (1.4%) at phylum level
(<xref rid="B14" ref-type="bibr">Gardner et al. 2013)</xref>.</p><p>Some aerobic bacteria presented decreased levels in LCL lesions. For
instance,<italic>Lactobacillus</italic> and <italic>Pseudomonas</italic> play
important protective roles on skin by the production of lactic acid, antimicrobial, and
antifungal compounds, respectively (<xref rid="B7" ref-type="bibr">Cogen et al.
2008</xref>, <xref rid="B41" ref-type="bibr">Slover &#x00026; Danziger 2008</xref>).
However, many other bacteria detected in our study were not previously associated with
the skin microbiome, that could be associated to high read number (687,952 reads mean
per sample), allowing identification of new microbiome components.</p><p>We observed that anaerobes (<italic>Fusobacterium</italic>,<italic>Bacteroides</italic>,
and <italic>Peptoniphilus</italic>), microaerophiles, and facultative anaerobic
(<italic>Streptococcus</italic>,<italic>Staphylococcus</italic>,
<italic>Morganella</italic>,<italic>Campylobacter</italic>, and
<italic>Arcanobacterium</italic>) bacteria were most frequently detected in LCL
(<xref ref-type="fig" rid="f06">Fig. 6</xref>), with a reduction of the aerobic
bacteria in normal skin. Similar results were observed in chronic wounds microbiome from
several aetiologies, which presented a significantly larger proportion of anaerobes
(<italic>Bacteroidetes</italic>,<italic>Fusobacterium</italic>), large quantities of
Gram-negative rods such as<italic>Pseudomonas</italic>, <italic>Proteus</italic>,
<italic>E. coli</italic>, and <italic>Klebsiella</italic>, and an increased
proportion of<italic>Staphylococcus</italic> and <italic>Streptococcus</italic>. Chronic
wounds also had a noticeably decreased proportion of protective coloniser in normal skin
(<xref rid="B22" ref-type="bibr">Han et al. 2011</xref>).</p><p>These anaerobic bacteria may survive in the oxygen presence at LCL lesions, as observed
in other wounds also exposed to air, by the symbiotically association with aerobic
species. These aerobic bacteria could consume oxygen, creating localised low oxygen
niches, allowing obligate anaerobes maintaining (<xref rid="B12" ref-type="bibr">Dowd et
al. 2008</xref>, <xref rid="B16" ref-type="bibr">Gontcharova et al. 2010</xref>).
Somehow, the infection-induced low oxygen microenvironment in LCL lesions could
contribute with <italic>Leishmania</italic> persistence, once hypoxia negatively
disturbs the killing of <italic>Leishmania</italic> due to type 2 NO synthase activity
reduction of macrophages (<xref rid="B10" ref-type="bibr">Das &#x00026; Lu 2014</xref>,
<xref rid="B29" ref-type="bibr">Mahnke et al. 2014)</xref>.</p><p>Analysing the differences in the skin microbiota at genus level,
only<italic>Streptococcus</italic> was significantly higher in LCL lesion. This genus
was previously linked to chronic ulcer infection (Issac-M&#x000e1;rquez &#x00026; Lezama-D&#x000e1;vila
2003, <xref rid="B40" ref-type="bibr">Shirazi et al. 2007</xref>,<xref rid="B12" ref-type="bibr">Dowd et al. 2008</xref>, <xref rid="B46" ref-type="bibr">Wolcott et al.
2009</xref>, <xref rid="B16" ref-type="bibr">Gontcharova et al. 2010)</xref> and
healing delay (<xref rid="B11" ref-type="bibr">Davies et al. 2004</xref>, <xref rid="B3" ref-type="bibr">Bertesteanu et al. 2014)</xref>. This suggests an important
role of<italic>Streptococcus</italic> in chronic wounds maintenance, as LCL lesions.</p><p>Interestingly, we observed in two of three patients (patients 5 and 10) with delayed
healing (take 2 or 3 Sb<sup>V</sup> cycles) an association of three bacterial
genera<italic>Streptococcus</italic>, <italic>Staphylococcus</italic>,
and<italic>Fusobacterium</italic> in a higher frequency (<xref ref-type="fig" rid="f05">Fig. 5</xref>). The other patient with delayed healing was excluded from
analysis due to sequencing issues. These three genera were found in HS samples from the
same patients; however, <italic>Streptococcus</italic> and<italic>Fusobacterium</italic>
showed a lower prevalence in HS and presented a high increase in LCL lesions. These
species alone seem not to influence healing time as observed in patients 1 and 2. These
findings suggest a synergistic effect of these three genera on the healing process of
LCL lesions. This was an interesting observation in our study; however it must be
confirmed by further studies due the small number of analysed patients with delayed
healing.</p><p>Ours results show the high bacterial community diversity in HS and LCL lesions. These
findings demonstrate that traditional evaluation by culturing pathogenic bacteria is
highly biased. The significant bacterial diversity reduction in LCL lesion microbiomes
shows predominance of <italic>Streptococcus</italic> and strict or facultative
anaerobes. It was also possible observe that microbial profile changes were directly
related to the delayed healing in two out of the 10 patients. In these patients,
<italic>Streptococcus</italic>, <italic>Staphylococcus</italic>,
and<italic>Fusobacterium</italic> concomitant infection were implicated in a complex
bacterial formation, leading to delayed healing. The present results provide insights
about the influence of these specific bacteria on healing time, although this
observation needs more investigation, due the sample size. Future investigations with
larger samples are required to improve the microbiome understanding at different body
sites. Moreover, temporal analyses are necessary to monitoring the microbiome changes
during the ulcer-healing course.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>To the volunteers who participated in this study, to the personnel of the Corte de Pedra
Health Post, for assistance with sample collection, to Regis Brandim Gomes, for the
sandfly cartoon, and to the undergraduate students and scientific initiation fellows,
Rodrigo Pessoa, Jaqueline T Watanabe, and Paula Calabria, for their help with DNA
isolation and barcoded library preparation.</p></ack><fn-group><fn fn-type="financial-disclosure" id="fn1"><p>Financial support: CNPq (479717/2011-7), NIH (AI088650), iii-INCT, INCT-D VRS was
supported by fellowships from CNPq and CAPES. VRS and ATLQ contributed equally to
this work.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alekseyenko</surname><given-names>AV</given-names></name><name><surname>Perez-Perez</surname><given-names>GI</given-names></name><name><surname>Souza</surname><given-names>A</given-names></name><name><surname>Strober</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Bihan</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Meth&#x000e9;</surname><given-names>BA</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group><year>2013</year><article-title>Community differentiation of the cutaneous microbiota in
psoriasis</article-title><source>Microbiome</source><volume>1</volume><size units="pages">31</size></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azeredo-Coutinho</surname><given-names>RBG</given-names></name><name><surname>Mendon&#x000e7;a</surname><given-names>SCF</given-names></name><name><surname>Callahan</surname><given-names>H</given-names></name><name><surname>Portal</surname><given-names>AC</given-names></name><name><surname>Gr&#x000f6;gl</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Sensitivity of Leishmania braziliensis promastigotes to meglumine
antimoniate (glucantime) is higher than that of other Leishmania species and
correlates with response to therapy in American tegumentary
leishmaniasis</article-title><source>J Parasitol</source><volume>93</volume><fpage>688</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">17626365</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertesteanu</surname><given-names>S</given-names></name><name><surname>Triaridis</surname><given-names>S</given-names></name><name><surname>Stankovic</surname><given-names>M</given-names></name><name><surname>Lazar</surname><given-names>V</given-names></name><name><surname>Chifiriuc</surname><given-names>MC</given-names></name><name><surname>Vlad</surname><given-names>M</given-names></name><name><surname>Grigore</surname><given-names>R</given-names></name></person-group><year>2014</year><article-title>Polymicrobial wound infections: pathophysiology and current
therapeutic approaches</article-title><source>Int J Pharm</source><volume>463</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">24361265</pub-id></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittencourt</surname><given-names>A</given-names></name><name><surname>Barral</surname><given-names>A</given-names></name><name><surname>Jesus</surname><given-names>AR</given-names></name><name><surname>Almeida</surname><given-names>RP</given-names></name><name><surname>Grimaldi</surname><given-names>G</given-names><suffix>Jr</suffix></name></person-group><year>1989</year><article-title>In situ identification of Leishmania amazonensis associated with
diffuse cutaneous leishmaniasis in Bahia, Brazil</article-title><source>Mem Inst Oswaldo Cruz</source><volume>84</volume><fpage>585</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">2487456</pub-id></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Lauber</surname><given-names>CL</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Berg-Lyons</surname><given-names>D</given-names></name><name><surname>Huntley</surname><given-names>J</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><name><surname>Owens</surname><given-names>SM</given-names></name><name><surname>Betley</surname><given-names>J</given-names></name><name><surname>Fraser</surname><given-names>L</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Gormley</surname><given-names>N</given-names></name><name><surname>Gilbert</surname><given-names>JA</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><year>2012</year><article-title>Ultra-high-throughput microbial community analysis on the Illumina
HiSeq and MiSeq platforms</article-title><source>ISME J</source><volume>6</volume><fpage>1621</fpage><lpage>1624</lpage><pub-id pub-id-type="pmid">22402401</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Lauber</surname><given-names>CL</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Berg-Lyons</surname><given-names>D</given-names></name><name><surname>Lozupone</surname><given-names>CA</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><year>2011</year><article-title>Global patterns of 16S rRNA diversity at a depth of millions of
sequences per sample</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><issue>1</issue><fpage>4516</fpage><lpage>4522</lpage><pub-id pub-id-type="pmid">20534432</pub-id></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogen</surname><given-names>AL</given-names></name><name><surname>Nizet</surname><given-names>V</given-names></name><name><surname>Gallo</surname><given-names>RL</given-names></name></person-group><year>2008</year><article-title>Skin microbiota: a source of disease or defence?</article-title><source>Br J Dermatol</source><volume>158</volume><fpage>442</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">18275522</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>JML</given-names></name><name><surname>Saldanha</surname><given-names>ACR</given-names></name><name><surname>Nasciento</surname><given-names>D</given-names></name><name><surname>Sampaio</surname><given-names>G</given-names></name><name><surname>Carneiro</surname><given-names>F</given-names></name><name><surname>Silva</surname><given-names>LM</given-names></name><name><surname>Barral</surname><given-names>A</given-names></name></person-group><year>2009</year><article-title>Clinical modalities, diagnosis, and therapeutic approach of the
tegumentary leishmaniasis in Brazil</article-title><source>Gaz Med Bahia</source><volume>79</volume><issue>3</issue><fpage>70</fpage><lpage>83</lpage></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daltrey</surname><given-names>DC</given-names></name><name><surname>Rhodes</surname><given-names>B</given-names></name><name><surname>Chattwood</surname><given-names>JG</given-names></name></person-group><year>1981</year><article-title>Investigation into the microbial flora of healing and non-healing
decubitus ulcers</article-title><source>J Clin Pathol</source><volume>34</volume><fpage>701</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">6790579</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>LM</given-names></name><name><surname>Lu</surname><given-names>KQ</given-names></name></person-group><year>2014</year><article-title>The virtues of oxygenation: low tissue oxygen adversely affects the
killing of Leishmania</article-title><source>J Invest Dermatol</source><volume>134</volume><fpage>2303</fpage><lpage>2305</lpage><pub-id pub-id-type="pmid">25120145</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>CE</given-names></name><name><surname>Hill</surname><given-names>KE</given-names></name><name><surname>Wilson</surname><given-names>MJ</given-names></name><name><surname>Stephens</surname><given-names>P</given-names></name><name><surname>Hill</surname><given-names>CM</given-names></name><name><surname>Harding</surname><given-names>KG</given-names></name><name><surname>Thomas</surname><given-names>DW</given-names></name></person-group><year>2004</year><article-title>Use of 16S ribosomal DNA PCR and denaturing gradient gel
electrophoresis for analysis of the microfloras of healing and nonhealing chronic
venous leg ulcers</article-title><source>J Clin Microbiol</source><volume>42</volume><fpage>3549</fpage><lpage>3557</lpage><pub-id pub-id-type="pmid">15297496</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowd</surname><given-names>SE</given-names></name><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>McKeehan</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Rhoads</surname><given-names>D</given-names></name></person-group><year>2008</year><article-title>Polymicrobial nature of chronic diabetic foot ulcer biofilm infections
determined using bacterial tag encoded FLX amplicon pyrosequencing
(bTEFAP)</article-title><source>PLoS ONE</source><volume>3</volume><elocation-id/></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontes</surname><given-names>CO</given-names></name><name><surname>Carvalho</surname><given-names>MAR</given-names></name><name><surname>Nicoli</surname><given-names>JR</given-names></name><name><surname>Hamdan</surname><given-names>JS</given-names></name><name><surname>Mayrink</surname><given-names>W</given-names></name><name><surname>Genaro</surname><given-names>O</given-names></name><name><surname>Carmo</surname><given-names>LS</given-names></name><name><surname>Farias</surname><given-names>LM</given-names></name></person-group><year>2005</year><article-title>Identification and antimicrobial susceptibility of micro-organisms
recovered from cutaneous lesions of human American tegumentary leishmaniasis in
Minas Gerais, Brazil</article-title><source>J Med Microbiol</source><volume>54</volume><fpage>1071</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">16192439</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>SE</given-names></name><name><surname>Hillis</surname><given-names>SL</given-names></name><name><surname>Heilmann</surname><given-names>K</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name><name><surname>Grice</surname><given-names>EA</given-names></name></person-group><year>2013</year><article-title>The neuropathic diabetic foot ulcer microbiome is associated with
clinical factors</article-title><source>Diabetes</source><volume>62</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">23139351</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>EGR</given-names></name><name><surname>Reis</surname><given-names>SA</given-names><suffix>Filho</suffix></name><name><surname>Oliveira</surname><given-names>EG</given-names></name><name><surname>Pareira</surname><given-names>ALN</given-names></name><name><surname>Silva</surname><given-names>AR</given-names></name><name><surname>Costa</surname><given-names>JML</given-names></name></person-group><year>2009</year><article-title>Bacterial infection in cutaneous leishmaniasis: bacterial pattern and
sensitivity to antibiotics</article-title><source>Rev Soc Bras Med Trop</source><volume>42</volume><fpage>219</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">19448948</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gontcharova</surname><given-names>V</given-names></name><name><surname>Youn</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name></person-group><year>2010</year><article-title>A comparison of bacterial composition in diabetic ulcers and
contralateral intact skin</article-title><source>Open Microbiol J</source><volume>4</volume><fpage>8</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">20461221</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>EA</given-names></name><name><surname>Kong</surname><given-names>HH</given-names></name><name><surname>Conlan</surname><given-names>S</given-names></name><name><surname>Deming</surname><given-names>CB</given-names></name><name><surname>Davis</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>AC</given-names></name><collab>NISC Comparative Sequencing Program</collab><name><surname>Bouffard</surname><given-names>GG</given-names></name><name><surname>Blakesley</surname><given-names>RW</given-names></name><name><surname>Murray</surname><given-names>PR</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Turner</surname><given-names>ML</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name></person-group><year>2009</year><article-title>Topographical and temporal diversity of the human skin
microbiome</article-title><source>Science</source><volume>324</volume><fpage>1190</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">19478181</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>EA</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name></person-group><year>2011</year><article-title>The skin microbiome</article-title><source>Nat Rev Microbiol</source><volume>9</volume><fpage>244</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">21407241</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>EA</given-names></name><name><surname>Snitkin</surname><given-names>ES</given-names></name><name><surname>Yockey</surname><given-names>LJ</given-names></name><name><surname>Bermudez</surname><given-names>DM</given-names></name><name><surname>Liechty</surname><given-names>KW</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name></person-group><year>2010</year><article-title>Longitudinal shift in diabetic wound microbiota correlates with
prolonged skin defense response</article-title><source>Proc Natl Acad Sci USA</source><volume>107</volume><fpage>14799</fpage><lpage>14804</lpage><pub-id pub-id-type="pmid">20668241</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Tesh</surname><given-names>RB</given-names></name><name><surname>McMahon-Pratt</surname><given-names>D</given-names></name></person-group><year>1989</year><article-title>A review of the geographic distribution and epidemiology of
leishmaniasis in the New World</article-title><source>Am J Trop Med Hyg</source><volume>41</volume><fpage>687</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">2701633</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbert</surname><given-names>AR</given-names></name><name><surname>Stacey</surname><given-names>MC</given-names></name><name><surname>Rohr</surname><given-names>JB</given-names></name><name><surname>Jopp-McKay</surname><given-names>A</given-names></name></person-group><year>1992</year><article-title>The effect of bacterial colonization on venous ulcer
healing</article-title><source>Australas J Dermatol</source><volume>33</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">1294056</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Zenilman</surname><given-names>JM</given-names></name><name><surname>Melendez</surname><given-names>JH</given-names></name><name><surname>Shirtliff</surname><given-names>ME</given-names></name><name><surname>Agostinho</surname><given-names>A</given-names></name><name><surname>James</surname><given-names>G</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><name><surname>Rao</surname><given-names>D</given-names></name><name><surname>Rickard</surname><given-names>AH</given-names></name><name><surname>Lazarus</surname><given-names>GS</given-names></name></person-group><year>2011</year><article-title>The importance of a multi-faceted approach to characterizing the
microbial flora of chronic wounds</article-title><source>Wound Repair Regen</source><volume>19</volume><fpage>532</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">22092791</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaac-M&#x000e1;rquez</surname><given-names>AP</given-names></name><name><surname>Lezama-D&#x000e1;vila</surname><given-names>CM</given-names></name></person-group><year>2003</year><article-title>Detection of pathogenic bacteria in skin lesions of patients with
chiclero&#x02019;s ulcer. Reluctant response to antimonial treatment</article-title><source>Mem Inst Oswaldo Cruz</source><volume>98</volume><fpage>1093</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">15049096</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>HH</given-names></name><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Deming</surname><given-names>C</given-names></name><name><surname>Conlan</surname><given-names>S</given-names></name><name><surname>Grice</surname><given-names>EA</given-names></name><name><surname>Beatson</surname><given-names>MA</given-names></name><name><surname>Nomicos</surname><given-names>E</given-names></name><name><surname>Polley</surname><given-names>EC</given-names></name><name><surname>Komarow</surname><given-names>HD</given-names></name><name><surname>Mullikin</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Blakesley</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Chu</surname><given-names>G</given-names></name><name><surname>Ramsahoye</surname><given-names>C</given-names></name><name><surname>Lovett</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Legaspi</surname><given-names>R</given-names></name><name><surname>Sison</surname><given-names>C</given-names></name><name><surname>Montemayor</surname><given-names>C</given-names></name><name><surname>Gregory</surname><given-names>M</given-names></name><name><surname>Hargrove</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Riebow</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name><name><surname>Novotny</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>J</given-names></name><name><surname>Benjamin</surname><given-names>B</given-names></name><name><surname>Brooks</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>H</given-names></name></person-group><year>2012</year><article-title>Temporal shifts in the skin microbiome associated with disease flares
and treatment in children with atopic dermatitis</article-title><source>Genome Res</source><volume>22</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">22310478</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>HH</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name></person-group><year>2012</year><article-title>Skin microbiome: looking back to move forward</article-title><source>J Invest Dermatol</source><volume>132</volume><fpage>933</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">22189793</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuczynski</surname><given-names>J</given-names></name><name><surname>Stombaugh</surname><given-names>J</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><year>2012</year><article-title>Using QIIME to analyze 16S rRNA gene sequences from microbial
communities</article-title><source>Curr Protoc Microbiol</source><volume>01</volume><comment>Unit-1E.5</comment></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>ME</given-names></name><name><surname>Carneiro</surname><given-names>MB</given-names></name><name><surname>Santos</surname><given-names>LM</given-names></name><name><surname>Vieira</surname><given-names>LQ</given-names></name></person-group><year>2016</year><article-title>Indigenous microbiota and leishmaniasis</article-title><source>Parasite Immunol</source><volume>38</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">26407073</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>P</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>C</given-names></name><name><surname>Silva</surname><given-names>AT</given-names></name><name><surname>Almeida</surname><given-names>RP</given-names></name><name><surname>D&#x02019;Oliveira</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Bittencourt</surname><given-names>A</given-names></name><name><surname>Carvalho</surname><given-names>EM</given-names></name></person-group><year>2002</year><article-title>Failure of early treatment of cutaneous leishmaniasis in preventing
the development of an ulcer</article-title><source>Clin Infect Dis</source><volume>34</volume><fpage>E69</fpage><lpage>E73</lpage><pub-id pub-id-type="pmid">12032913</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahnke</surname><given-names>A</given-names></name><name><surname>Meier</surname><given-names>RJ</given-names></name><name><surname>Schatz</surname><given-names>V</given-names></name><name><surname>Hofmann</surname><given-names>J</given-names></name><name><surname>Castiglione</surname><given-names>K</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Wolfbeis</surname><given-names>OS</given-names></name><name><surname>Bogdan</surname><given-names>C</given-names></name><name><surname>Jantsch</surname><given-names>J</given-names></name></person-group><year>2014</year><article-title>Hypoxia in Leishmania major skin lesions impairs the NO-dependent
leishmanicidal activity of macrophages</article-title><source>J Invest Dermatol</source><volume>134</volume><fpage>2339</fpage><lpage>2346</lpage><pub-id pub-id-type="pmid">24583949</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitropoulos</surname><given-names>P</given-names></name><name><surname>Konidas</surname><given-names>P</given-names></name><name><surname>Durkin-Konidas</surname><given-names>M</given-names></name></person-group><year>2010</year><article-title>New World cutaneous leishmaniasis: updated review of current and
future diagnosis and treatment</article-title><source>J Am Acad Dermatol</source><volume>63</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">20303613</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Wilhelm</surname><given-names>C</given-names></name><name><surname>Molloy</surname><given-names>MJ</given-names></name><name><surname>Salcedo</surname><given-names>R</given-names></name><name><surname>Kastenmuller</surname><given-names>W</given-names></name><name><surname>Deming</surname><given-names>C</given-names></name><name><surname>Quinones</surname><given-names>M</given-names></name><name><surname>Koo</surname><given-names>L</given-names></name><name><surname>Conlan</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>S</given-names></name><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Dzutsev</surname><given-names>A</given-names></name><name><surname>Kong</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>DJ</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group><year>2012</year><article-title>Compartmentalized control of skin immunity by resident
commensals</article-title><source>Science</source><volume>337</volume><fpage>1115</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">22837383</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>MR</given-names></name><name><surname>Tafuri</surname><given-names>WL</given-names></name><name><surname>Afonso</surname><given-names>LC</given-names></name><name><surname>Oliveira</surname><given-names>MA</given-names></name><name><surname>Nicoli</surname><given-names>JR</given-names></name><name><surname>Vieira</surname><given-names>EC</given-names></name><name><surname>Scott</surname><given-names>P</given-names></name><name><surname>Melo</surname><given-names>MN</given-names></name><name><surname>Vieira</surname><given-names>LQ</given-names></name></person-group><year>2005</year><article-title>Germ-free mice produce high levels of interferon-g in response to
infection with Leishmania major but fail to heal lesions</article-title><source>Parasitology</source><volume>131</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">16174412</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percival</surname><given-names>SL</given-names></name><name><surname>Thomas</surname><given-names>JG</given-names></name><name><surname>Williams</surname><given-names>DW</given-names></name></person-group><year>2010</year><article-title>Biofilms and bacterial imbalances in chronic wounds:
anti-Koch</article-title><source>Int Wound J</source><volume>7</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">20602647</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reithinger</surname><given-names>R</given-names></name><name><surname>Dujardin</surname><given-names>J</given-names></name><name><surname>Louzir</surname><given-names>H</given-names></name></person-group><year>2007</year><article-title>Cutaneous leishmaniasis</article-title><source>Lancet Infect Dis</source><volume>7</volume><fpage>581</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">17714672</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhoads</surname><given-names>DD</given-names></name><name><surname>Cox</surname><given-names>SB</given-names></name><name><surname>Rees</surname><given-names>EJ</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wolcott</surname><given-names>RD</given-names></name></person-group><year>2012</year><article-title>Clinical identification of bacteria in human chronic wound infections:
culturing vs. 16S ribosomal DNA sequencing</article-title><source>BMC Infect Dis</source><volume>12</volume><size units="pages">321</size></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>AC</given-names></name><name><surname>Cuba</surname><given-names>CC</given-names></name><name><surname>Vexenat</surname><given-names>A</given-names></name><name><surname>Barreto</surname><given-names>AC</given-names></name><name><surname>Marsden</surname><given-names>PD</given-names></name></person-group><year>1988</year><article-title>Predominance of Leishmania braziliensis in the regions of Tr&#x000ea;s Bra&#x000e7;os
and Corte de Pedra, Bahia, Brazil</article-title><source>Trans R Soc Trop Med Hyg</source><volume>82</volume><fpage>409</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">3232172</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeghian</surname><given-names>G</given-names></name><name><surname>Ziaei</surname><given-names>H</given-names></name><name><surname>Bidabadi</surname><given-names>LS</given-names></name><name><surname>Baghbaderani</surname><given-names>AZ</given-names></name></person-group><year>2011</year><article-title>Decreased effect of glucantime in cutaneous leishmaniasis complicated
with secondary bacterial infection</article-title><source>Indian J Dermatol</source><volume>56</volume><fpage>37</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21572789</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>S</given-names></name></person-group><year>1999</year><article-title>Cutaneous leishmaniasis: clinical features and
diagnosis</article-title><source>Clin Dermatol</source><volume>17</volume><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">10384868</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scales</surname><given-names>BS</given-names></name><name><surname>Huffnagle</surname><given-names>GB</given-names></name></person-group><year>2013</year><article-title>The microbiome in wound repair and tissue fibrosis</article-title><source>J Pathol</source><volume>229</volume><fpage>323</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">23042513</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirazi</surname><given-names>MH</given-names></name><name><surname>Ranjbar</surname><given-names>R</given-names></name><name><surname>Asgari</surname><given-names>V</given-names></name><name><surname>Mohebali</surname><given-names>M</given-names></name><name><surname>Hamidian</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Study of bacterial infections among the patients with suspected
cutaneous leishmaniasis</article-title><source>Pak J Biol Sci</source><volume>10</volume><fpage>4555</fpage><lpage>4558</lpage><pub-id pub-id-type="pmid">19093532</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slover</surname><given-names>CM</given-names></name><name><surname>Danziger</surname><given-names>L</given-names></name></person-group><year>2008</year><article-title>Lactobacillus: a Review</article-title><source>Clin Microbiol Newsl</source><volume>30</volume><fpage>23</fpage><lpage>27</lpage></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>LA</given-names></name><name><surname>Macedo</surname><given-names>JLS</given-names></name><name><surname>Ciuffo</surname><given-names>IA</given-names></name><name><surname>Santos</surname><given-names>CG</given-names></name><name><surname>Santos</surname><given-names>JB</given-names></name></person-group><year>2006</year><article-title>Antimicrobial susceptibility of aerobic bacteria isolated from
leishmaniotic ulcers in Corte de Pedra, BA</article-title><source>Rev Soc Bras Med Trop</source><volume>39</volume><fpage>47</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16501766</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>LA</given-names></name><name><surname>Mac&#x000ea;do</surname><given-names>VO</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>AV</given-names></name><name><surname>Ciuffo</surname><given-names>IA</given-names></name><name><surname>Santos</surname><given-names>CG</given-names></name><name><surname>Santos</surname><given-names>JB</given-names></name></person-group><year>2002</year><article-title>Cutaneous leishmaniotic ulcers with Corynebacterium
diphtheriae</article-title><source>Rev Soc Bras Med Trop</source><volume>35</volume><fpage>311</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">12170325</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>LQ</given-names></name><name><surname>Oliveira</surname><given-names>MR</given-names></name><name><surname>Neumann</surname><given-names>E</given-names></name><name><surname>Nicoli</surname><given-names>JR</given-names></name><name><surname>Vieira</surname><given-names>EC</given-names></name></person-group><year>1998</year><article-title>Parasitic infections in germ-free animals</article-title><source>Braz J Med Biol Res</source><volume>31</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">9686185</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weirather</surname><given-names>JL</given-names></name><name><surname>Jer&#x000f4;nimo</surname><given-names>SMB</given-names></name><name><surname>Gautam</surname><given-names>S</given-names></name><name><surname>Sundar</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Kurtz</surname><given-names>MA</given-names></name><name><surname>Haque</surname><given-names>R</given-names></name><name><surname>Schriefer</surname><given-names>A</given-names></name><name><surname>Talhari</surname><given-names>S</given-names></name><name><surname>Carvalho</surname><given-names>EM</given-names></name><name><surname>Donelson</surname><given-names>JE</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name></person-group><year>2011</year><article-title>Serial quantitative PCR assay for detection, species discrimination,
and quantification of Leishmania spp in human samples</article-title><source>J Clin Microbiol</source><volume>49</volume><fpage>3892</fpage><lpage>3904</lpage><pub-id pub-id-type="pmid">22042830</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Gontcharova</surname><given-names>V</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zischakau</surname><given-names>A</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name></person-group><year>2009</year><article-title>Bacterial diversity in surgical site infections: not just aerobic
cocci any more</article-title><source>J Wound Care</source><volume>18</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">19862869</pub-id></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziaei</surname><given-names>H</given-names></name><name><surname>Sadeghian</surname><given-names>G</given-names></name><name><surname>Hejazi</surname><given-names>SH</given-names></name></person-group><year>2008</year><article-title>Distribution frequency of pathogenic bacteria isolated from cutaneous
leishmaniasis lesions</article-title><source>Korean J Parasitol</source><volume>46</volume><fpage>191</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">18830062</pub-id></element-citation></ref></ref-list></back></article>